Yesterday, Kinaxis reported its Q4 and fiscal 2016 results. In the fourth quarter, the company posted Adjusted EBITDA of $6.4-million on revenue of $30.3-million, a topline that was up 25 per cent over the same period a year earlier.
“Two thousand sixteen was another year of strong revenue and new customer growth. We delivered solid bottom-line results as we continued to make strategic investments to scale our business,” said CEO John Sicard. “The world’s largest companies have increasingly recognized that concurrent planning represents the future of effective supply chain management. Through RapidResponse, we are delivering on this promise and enabling our customers to pro-actively react to change. Our partner relationships continue to progress well and have supported a number of key wins in 2016. Our partners work to improve operational and financial performance for their clients by utilizing RapidResponse’s capabilities. With a strong platform in place, we enter 2017 in a great position to leverage our technology, customer relationships and strategic partners to continue to produce solid results.”
Abernethy says the quarter was about what he expected, with EBITDA a bit lower than he had modeled and revenue hitting his target exactly. With a more long-term approach, he says he believes these are early days for the Ottawa-based supply chain solutions provider.
“We continue to believe that Kinaxis is still in the relatively early stages of a long-term secular manufacturing industry technology growth opportunity,” says the analyst. “We see several upcoming potential catalysts for Kinaxis’ stock, including large new customer contract wins, traction in new(er) verticals, such as automotive, improved partner contributions, and further expansion of the product offering.”
Abernethy today maintained his “Buy” rating on Kinaxis.
Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]
Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]
Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]
A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]
Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]
The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]